ConductScience.org, home

Paper363377

Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.

Chabner BA and 4 others. Drug Metab Rev, 1978. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion. Papers, record 363377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/363377

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.
PubMed
Journal
Drug Metab Rev
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
0.85
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chabner BAB A
2Stoller RGR G
3Hande KK
4Jacobs SS
5Young RCR C

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethotrexateMajor topic
Ovarian NeoplasmsMajor topic
Ascites
Drug Resistance
Female
Humans
Infusions, Parenteral
Kinetics

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
39527259Periprosthetic seromas and a third space effect after high-dose methotrexate.Wien Klin Wochenschr2025https://conductscience.org/library/papers/39527259PubMed
38440732Endoplasmic reticulum stress in breast cancer: a predictive model for prognosis and therapy selection.Front Immunol2024https://conductscience.org/library/papers/38440732PubMed
35610338Molecular relation between biological stress and carcinogenesis.Mol Biol Rep2022https://conductscience.org/library/papers/35610338PubMed
11368290All half-lives are wrong, but some half-lives are useful.Clin Pharmacokinet2001https://conductscience.org/library/papers/11368290PubMed
3370743The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3370743PubMed
3052986Clinical pharmacokinetics of drugs used in the treatment of breast cancer.Clin Pharmacokinet1988https://conductscience.org/library/papers/3052986PubMed
2689182The effects of diltiazem on methotrexate-induced nephrotoxicity.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2689182PubMed
527209High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/527209PubMed
373916High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/373916PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/363377

GET https://conductscience.org/api/papers/v1/363377/authors